These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30946047)

  • 1. Sildenafil for Pulmonary Arterial Hypertension.
    Bhogal S; Khraisha O; Al Madani M; Treece J; Baumrucker SJ; Paul TK
    Am J Ther; 2019; 26(4):e520-e526. PubMed ID: 30946047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A focus on riociguat in the treatment of pulmonary arterial hypertension.
    Toxvig AK; Wehland M; Grimm D; Infanger M; Krüger M
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):202-214. PubMed ID: 31206240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
    D'Agostino A; Lanzafame LG; Buono L; Crisci G; D'Assante R; Leone I; De Vito L; Bossone E; Cittadini A; Marra AM
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203205
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Peng Y; Dai J; Zhao YY
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension].
    Beltrán-Gámez ME; Sandoval-Zárate J; Pulido T
    Arch Cardiol Mex; 2015; 85(3):215-24. PubMed ID: 26047999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Hoeper MM; Ewert R; Jansa P; Sirenko Y; Skride A; Balagtas C; Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ
    Circulation; 2024 Jun; 149(25):1949-1959. PubMed ID: 38752352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
    Pinto VM; Derchi GE; Bacigalupo L; Pontali E; Forni GL
    Hemoglobin; 2020 May; 44(3):218-220. PubMed ID: 32552139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
    Kido K; Coons JC
    Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in targeted therapy for pulmonary arterial hypertension in children.
    Li L; Zhu X; Chen X; Gao J; Ding C; Zhang M; Ma S
    Eur J Pediatr; 2023 May; 182(5):2067-2076. PubMed ID: 36527480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
    Mandras S; Kovacs G; Olschewski H; Broderick M; Nelsen A; Shen E; Champion H
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):453-462. PubMed ID: 33836637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment.
    Grünig E; Ohnesorge J; Benjamin N; Burhenne J; Enderle Y; Egenlauf B; Fischer C; Harutyunova S; Huppertz A; Klose H; Haefeli WE
    Respiration; 2017; 94(1):26-37. PubMed ID: 28494463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications.
    Ala M; Mohammad Jafari R; Dehpour AR
    Fundam Clin Pharmacol; 2021 Apr; 35(2):235-259. PubMed ID: 33226665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sildenafil Citrate on Pulmonary Arterial Systolic Pressure and Sub-maximal Exercise Capacity in Chronic Obstructive Pulmonary Disease.
    Shrestha SK; Srivastava B; Karki M; Khatri DB; Pradhan RM
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):271-278. PubMed ID: 30580340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
    BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.
    Zheng W; Wang Z; Jiang X; Zhao Q; Shen J
    J Med Chem; 2020 Dec; 63(24):15153-15186. PubMed ID: 33314936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat].
    Martynyuk TV; Shmalts AA; Gorbachevsky SV; Chazova IE
    Ter Arkh; 2021 Sep; 93(9):1117-1124. PubMed ID: 36286873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study.
    Hidayati F; Gharini PPR; Hartopo AB; Anggrahini DW; Dinarti LK
    Health Qual Life Outcomes; 2020 Aug; 18(1):278. PubMed ID: 32795300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
    Oliynyk OV; Rorat M; Strepetova OV; Dubrov SO; Guryanov VG; Oliynyk YV; Kulivets OS; Ślifirczyk A; Barg W
    Viruses; 2023 May; 15(5):. PubMed ID: 37243243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.